In vitro |
EMiLy (INSERM U1160) |
Organoids |
MSD/AML |
3D Model (Artificial BM organoid) NK cells/MSC/blastes |
- |
- |
- |
|
In vitro |
CRCM / IPC (UMR-1068) |
PDX |
B-ALL |
- |
Diagnosis |
4 |
All |
|
In vitro |
CRCM / IPC (UMR-1068) |
PDX |
B-ALL |
- |
Relapse |
4 |
All |
|
In vitro |
CRCM / IPC (UMR-1068) |
PDX |
AML |
- |
Diagnosis |
10 |
All |
|
In vitro |
CRCM / IPC (UMR-1068) |
PDX |
B-ALL |
- |
- |
9 |
All |
|
In vitro |
CRCM / IPC (UMR-1068) |
PDX |
AML |
- |
Relapse |
14 |
All |
|
In vitro |
CRCM / IPC (UMR-1068) |
PDX |
AML |
- |
- |
8 |
All |
|
In vitro |
CRCM / IPC (UMR-1068) |
CDX |
T-ALL |
- |
- |
3 |
- |
|
In vitro |
CRCM / IPC (UMR-1068) |
CDX |
AML |
- |
- |
10 |
- |
|
In vitro |
CRCM / IPC (UMR-1068) |
CDX |
APDCL |
- |
- |
2 |
- |
|
In vitro |
C3M (UMR-1065) |
Human primary cells |
AML |
- |
Diagnosis |
- |
- |
|
In vitro |
C3M (UMR-1065) |
Human primary cells |
AML |
- |
Relapse |
- |
- |
|
In vitro |
CRCT (UMR-1037) |
Human primary cells |
B-ALL |
- |
Diagnosis |
- |
- |
|
In vitro |
CRCT (UMR-1037) |
Human primary cells |
B-ALL |
- |
Relapse |
- |
- |
|
In vitro |
UMR - 1274 |
Human primary cells |
T-ALL |
- |
Diagnosis |
- |
- |
|
In vitro |
UMR - 1274 |
Human primary cells |
T-ALL |
- |
Relapse |
- |
- |
|
In vitro |
IDMIT (UMR-1184) |
Human primary cells |
AML |
Mononuclear myeloid cells (MMC) |
Diagnosis |
- |
- |
|
In vitro |
IDMIT (UMR-1184) |
Human primary cells |
AML |
Mononuclear myeloid cells (MMC) |
Diagnosis |
- |
- |
|
In vitro |
U1069-N2COx |
Human primary cells |
AML |
- |
Diagnosis |
- |
- |
|
In vitro |
U1069-N2COx |
Human primary cells |
AML |
- |
Relapse |
- |
- |
|
In vitro |
Cochin Institute (UMR-1016) |
Human primary cells |
AML |
- |
Diagnosis |
- |
- |
|
In vitro |
Cochin Institute (UMR-1016) |
Human primary cells |
AML |
- |
Relapse |
- |
- |
|
In vitro |
U1312 BRIC |
Human primary cells |
AML |
- |
Diagnosis |
- |
- |
|
In vitro |
U1312 BRIC |
Human primary cells |
AML |
- |
Relapse |
- |
- |
|
In vitro |
CRSA (UMR-938) |
Human primary cells |
DNMT3A AML |
- |
Diagnosis |
- |
All |
|
In vitro |
CRSA (UMR-938) |
Human primary cells |
DNMT3A AML |
- |
Relapse |
- |
All |
|
In vitro |
CRSA (UMR-938) |
Human primary cells |
TET2 AML |
- |
Diagnosis |
- |
All |
|
In vitro |
CRSA (UMR-938) |
Human primary cells |
TET2 AML |
- |
Relapse |
- |
All |
|
In vitro |
CRSA (UMR-938) |
Human primary cells |
TP53 AML |
- |
Diagnosis |
- |
All |
|
In vitro |
CRSA (UMR-938) |
Human primary cells |
TP53 AML |
- |
Relapse |
- |
All |
|
In vitro |
IDMIT (UMR-1184) |
Human primary cells |
CML |
CD34+ cells |
Diagnosis |
- |
- |
|
In vitro |
C3M (UMR-1065) |
Human primary cells |
CMML |
- |
Diagnosis |
- |
- |
|
In vitro |
C3M (UMR-1065) |
Human primary cells |
CMML |
- |
Relapse |
- |
- |
|
In vitro |
U1069-N2COx |
Human primary cells |
Normal bone marrow |
- |
- |
- |
- |
|
In vitro |
CRSA (UMR-938) |
Human primary cells |
Shwachman Diamond |
- |
Follow-up |
- |
- |
|
In vitro |
Cochin Institute (UMR-1016) |
Human primary cells |
MDS |
- |
Diagnosis |
- |
- |
|
In vitro |
Cochin Institute (UMR-1016) |
Human primary cells |
MDS |
- |
Evolution |
- |
- |
|
In vitro |
C3M (UMR-1065) |
Human primary cells |
MDS |
- |
Diagnosis |
- |
- |
|
In vitro |
C3M (UMR-1065) |
Human primary cells |
MDS |
- |
Relapse |
- |
- |
|
In vitro |
INSERM UMR-S 1131 (UMR-1131) |
Human primary cells |
ET, PV, MF |
- |
Diagnosis |
- |
All |
|
In vitro |
INSERM UMR-S 1131 (UMR-1131) |
Human primary cells |
ET, PV, MF |
- |
Follow-up |
- |
All |
|
In vitro |
CRSA (UMR-938) |
Transduced human primary cells |
DNMT3A Clonal Hematopoiesis |
- |
- |
- |
All |
|
In vitro |
CRSA (UMR-938) |
Transduced human primary cells |
TET2 Clonal Hematopoiesis |
- |
- |
- |
All |
|
In vitro |
CRSA (UMR-938) |
Transduced human primary cells |
TP53 Clonal Hematopoiesis |
- |
- |
- |
All |
|
In vitro |
UMR - 1274 |
Mouse tumor-derived cell line |
T-ALL |
ICN1 |
- |
- |
- |
|
In vitro |
UMR - 1274 |
Mouse tumor-derived cell line |
T-ALL |
TAL1/LMO1 |
- |
- |
- |
|
In vivo |
CRCM / IPC (UMR-1068) |
CDX |
T-ALL |
- |
- |
3 |
- |
|
In vivo |
CRCM / IPC (UMR-1068) |
CDX |
AML |
- |
- |
10 |
- |
|
In vivo |
CRCM / IPC (UMR-1068) |
CDX |
APDCL |
- |
- |
2 |
- |
|
In vitro |
CRCM / IPC (UMR-1068) |
Mouse tumor-derived cell line |
AML |
FLB1 |
- |
- |
- |
|
In vitro |
CRCM / IPC (UMR-1068) |
Mouse tumor-derived cell line |
AML |
C1498 |
- |
- |
- |
|
In vivo |
IDMIT (UMR-1184) |
Mouse model |
Myelofibrosis |
C57BL/6 (B6.129(Cg)-Leprtm2(cre)Rck/J (008320) _ B6.129-Ppargtm2Rev/J (004584)) |
- |
- |
- |
|
In vivo |
CRCT (UMR-1037) |
Mouse model |
B-ALL |
B-ALL Pax5-ELN |
- |
- |
- |
|
In vivo |
CRCT (UMR-1037) |
Mouse model |
B-ALL |
B-ALL PAX5-P80R |
- |
- |
- |
|
In vivo |
CRCT (UMR-1037) |
Mouse model |
AML |
KI Gata2µ/R396Q |
- |
- |
- |
|
In vivo |
Cochin Institute (UMR-1016) |
Mouse model |
AML |
MLL-AF9 |
- |
- |
- |
|
In vivo |
Cochin Institute (UMR-1016) |
Mouse model |
AML |
MLL-ENL |
- |
- |
- |
|
In vivo |
CRCM / IPC (UMR-1068) |
Mouse model |
AML |
iMLL-AF9 x Jam3 cKO |
- |
- |
- |
|
In vivo |
CRCM / IPC (UMR-1068) |
Mouse model |
AML |
cMLL-AF9 |
- |
- |
- |
|
In vivo |
U1312 BRIC |
Mouse model |
AML |
AML Meis/HoxA9 |
- |
- |
- |
|
In vivo |
U1312 BRIC |
Mouse model |
AML |
AML/AF9 |
- |
- |
- |
|
In vivo |
IDMIT (UMR-1184) |
Mouse model |
CML |
LMC-BCR-ABL |
- |
- |
- |
|
In vivo |
GenCellDis (UMR-944) |
Mouse model |
Fanconi anemia |
FANCG-/- |
- |
- |
- |
|
In vivo |
EMiLy (INSERM U1160) |
Mouse model |
Waldenström's macroglobulinemia |
Cxcr4+/1013 x Myd88B-L252P =Waldenstrom-like disease |
- |
- |
- |
|
In vivo |
IDMIT (UMR-1184) |
Mouse model |
Myelofibrosis |
Myelofibrosis TPOhigh |
- |
- |
- |
|
In vivo |
C3M (UMR-1065) |
Mouse model |
MSD/AML |
LAMP2-Vav-Cre |
- |
- |
- |
|
In vivo |
C3M (UMR-1065) |
Mouse model |
MSD/AML |
LAMP2-CEBPa |
- |
- |
- |
|
In vivo |
EMiLy (INSERM U1160) |
Mouse model |
Richter's Syndrome |
Cxcr4+/1013xEµ-TCL1=CLL/Richter syndrome like disease |
- |
- |
- |
|
In vivo |
U1069-N2COx |
Mouse model |
AML |
FLA2, FLB1 |
- |
- |
- |
|
In vivo |
CRCM / IPC (UMR-1068) |
PDX |
B-ALL |
- |
Diagnosis |
4 |
All |
|
In vivo |
CRCM / IPC (UMR-1068) |
PDX |
B-ALL |
- |
Relapse |
4 |
All |
|
In vivo |
CRCT (UMR-1037) |
PDX |
B-ALL |
- |
- |
5 |
Some |
|
In vivo |
CRCM / IPC (UMR-1068) |
PDX |
B-ALL |
- |
Diagnosis |
9 |
All |
|
In vivo |
UMR - 1274 |
PDX |
B-ALL |
- |
- |
8 |
All |
|
In vivo |
GenCellDis (UMR-944) |
PDX |
B-ALL |
- |
- |
- |
All |
|
In vivo |
CRCM / IPC (UMR-1068) |
PDX |
T-ALL |
- |
- |
7 |
All |
|
In vivo |
UMR - 1274 |
PDX |
T-ALL |
- |
- |
57 |
Some |
|
In vivo |
GenCellDis (UMR-944) |
PDX |
T-ALL |
- |
- |
- |
All |
|
In vivo |
IDMIT (UMR-1184) |
PDX |
AML |
- |
- |
- |
- |
|
In vivo |
CRCT (UMR-1037) |
PDX |
AML |
- |
- |
55 |
All |
|
In vivo |
CRCM / IPC (UMR-1068) |
PDX |
AML |
- |
Diagnosis |
10 |
All |
|
In vivo |
CRCM / IPC (UMR-1068) |
PDX |
AML |
- |
Relapse |
14 |
All |
|
In vivo |
CRCM / IPC (UMR-1068) |
PDX |
AML |
- |
- |
8 |
All |
|
In vivo |
UMR - 1274 |
PDX |
AML |
- |
- |
8 |
Some |
|
In vivo |
U1312 BRIC |
PDX |
FLT3-ITD AML |
- |
- |
- |
All |
|
In vivo |
CRCM / IPC (UMR-1068) |
PDX |
APDCL |
- |
- |
4 |
None |
|